Finnadvance

Oulu, Finland Founded: 2018 • Age: 8 yrs
Microfluidics and microtechnology solutions are developed for drug permeability testing.

About Finnadvance

Finnadvance is a company based in Oulu (Finland) founded in 2018 by Prateek Singh.. Finnadvance has raised $1.9 million across 4 funding rounds from investors including European Union, Athensmed and Takoa Invest. Finnadvance offers products and services including AKITA® Plate, AKITA® Lid, and AKITA® Wave. Finnadvance operates in a competitive market with competitors including ACXEL, SpacePharma, Axbio, Accel Diagnostics and Micronit, among others.

  • Headquarter Oulu, Finland
  • Founders Prateek Singh
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Finnadvance Ltd.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.9 M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.3 M (USD), Seed

    Apr 08, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Finnadvance

Finnadvance offers a comprehensive portfolio of products and services, including AKITA® Plate, AKITA® Lid, and AKITA® Wave. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

High-throughput platform for in-vitro drug testing models

Enables simultaneous TEER measurements in tissue cultures

Optimized device for compatible microfluidic research

People of Finnadvance
Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Jere Kettunen
Lead Biofabrication Engineer
People
Sebastien Mosser
Chief Scientific Officer
People
Anniina Palojärvi
Fabrication Engineer
People
Prateek Singh
CEO

Unlock access to complete

Funding Insights of Finnadvance

Finnadvance has successfully raised a total of $1.9M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.3 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Seed — $1.3M
  • First Round
  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2022 Amount Seed - Finnadvance Valuation Athensmed
Apr, 2022 Amount Grant - Finnadvance Valuation

investors

Apr, 2020 Amount Seed - Finnadvance Valuation Voima Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Finnadvance

Finnadvance has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Union, Athensmed and Takoa Invest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
A Finnish family-owned investment company focused on growth-oriented businesses.
Founded Year Domain Location
Funding is provided for deep tech ventures in Nordics.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Finnadvance

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Finnadvance

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Finnadvance Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Finnadvance

Finnadvance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, SpacePharma, Axbio, Accel Diagnostics and Micronit, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Microfluidic technology and solutions are provided for life sciences industries.
domain founded_year HQ Location
Microgravity research solutions are provided for researchers and companies.
domain founded_year HQ Location
Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI
domain founded_year HQ Location
Protein biomarkers are analyzed via lab-on-chip platform for disease monitoring.
domain founded_year HQ Location
Microfluidic devices and lab-on-chip solutions are designed and manufactured.
domain founded_year HQ Location
Developer of microfluidic chip and technology for life science research
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Finnadvance

Frequently Asked Questions about Finnadvance

When was Finnadvance founded?

Finnadvance was founded in 2018.

Where is Finnadvance located?

Finnadvance is headquartered in Oulu, Finland. It is registered at Oulu, North Ostrobothnia, Finland.

Who is the current CEO of Finnadvance?

Prateek Singh is the current CEO of Finnadvance. They have also founded this company.

Is Finnadvance a funded company?

Finnadvance is a funded company, having raised a total of $1.9M across 4 funding rounds to date. The company's 1st funding round was a Seed of $596.11K, raised on Dec 09, 2018.

What does Finnadvance do?

Finnadvance was founded in 2018 in Oulu, Finland, within the biotechnology sector. Microfluidics and microtechnology are utilized to create high-throughput biological barrier models on chips. These models replicate human tissues, including vascular, lung, and blood-brain barriers, for evaluating small molecule and nano-formulation permeability and toxicity. Dynamic cell cultures are employed to simulate in-vivo conditions, supporting drug development processes.

Who are the top competitors of Finnadvance?

Finnadvance's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.

What products or services does Finnadvance offer?

Finnadvance offers AKITA® Plate, AKITA® Lid, and AKITA® Wave.

Who are Finnadvance's investors?

Finnadvance has 7 investors. Key investors include European Union, Athensmed, Takoa Invest, Voima Ventures, and Icebreaker.vc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available